Table of contents

1. Introduction to Anatomy & Physiology5h 43m
2. Cell Chemistry & Cell Components12h 36m
3. Energy & Cell Processes10h 6m
4. Tissues & Histology10h 3m
5. Integumentary System2h 20m
6. Bones & Skeletal Tissue2h 16m
7. The Skeletal System2h 35m
8. Joints2h 17m
9. Muscle Tissue2h 33m
10. Muscles1h 11m
11. Nervous Tissue and Nervous System1h 35m
12. The Central Nervous System1h 6m
- Introduction to the Central Nervous System
  18m
- The Cerebrum
  48m
13. The Peripheral Nervous System1h 26m
14. The Autonomic Nervous System1h 38m
15. The Special Senses2h 41m
16. The Endocrine System2h 48m
17. The Blood3h 22m
18. The Heart3h 42m
19. The Blood Vessels3h 35m
20. The Lymphatic System3h 16m
21. The Immune System14h 37m
22. The Respiratory System3h 20m
23. The Digestive System2h 5m
24. Metabolism and Nutrition4h 0m
25. The Urinary System2h 39m
26. Fluid and Electrolyte Balance, Acid Base Balance37m
27. The Reproductive System2h 5m
28. Human Development1h 21m
29. Heredity3h 32m

29. Heredity

Genetic Disorders

Anatomy & Physiology

29. Heredity

Genetic Disorders

Previous problemNext problem

Struggling with Anatomy & Physiology?

Join thousands of students who trust us to help them ace their exams!Watch the first video

Multiple Choice

Amniocentesis and chorionic villus sampling are both examples of a category of genetic screening called __________.

fetal testing

genomic imprinting

carrier recognition

human gene therapy

Previous problemNext problem

Verified step by step guidance

Begin by understanding the purpose of amniocentesis and chorionic villus sampling. Both are procedures used to obtain samples from a pregnant woman to test for genetic abnormalities in the fetus.

Recognize that these procedures are part of a broader category of tests that aim to assess the genetic health of a fetus. This category is known as fetal testing.

Consider the other options provided: genomic imprinting, carrier recognition, and human gene therapy. Understand that genomic imprinting refers to the phenomenon where certain genes are expressed in a parent-of-origin-specific manner, which is not directly related to these procedures.

Carrier recognition involves identifying individuals who carry one copy of a gene mutation that, when present in two copies, causes a genetic disorder. This is typically done before conception and is not the focus of amniocentesis or chorionic villus sampling.

Human gene therapy involves modifying or manipulating genes to treat or prevent disease, which is a different approach from testing for genetic abnormalities in a fetus. Therefore, the correct category for amniocentesis and chorionic villus sampling is fetal testing.